Strain/modificationa | SS-like disease manifestationsb | Remarksb | Reference |
---|---|---|---|
(NZB/NZW)F1 | SG and LG infl. | SLE-like disease | [19] |
MRL | SG and LG infl. | SLE-like disease | [29] |
lpr | ↑ SG and LG infl. | lpr exacerbates the MRL disease phenotype | [30] |
NFS/sld | None | Aberrant proteolysis of α-fodrin | [33] |
3d-Tx | SG and LG infl. | Inflammatory lesions in multiple organs | [34] |
IQI/Jic | SG and LG infl. | Inflammatory lesions in multiple organs | [37] |
NOD | SG and LG infl., ↓ SG and LG function | T1D, multiple immune system-related alterations | [12] |
H2b | Similar to original NOD strain | No T1D | [42] |
C57BL/6 | May develop SG infl. at an old age | Widely used recipient strain | |
NOD-Aec1Aec2 | SG and LG infl., ↓ SG and LG function | Increased applicability compared with NOD mice | [41] |
Il2-/- | SG and LG infl., ↓ SG function | Generalized lymphoproliferative disease | [91] |
Il2Rα-/- | SG and LG infl., ↓ SG function | Generalized lymphoproliferative disease | [91] |
Foxp3-/- | None | More susceptible to SS-like disease | [94] |
Il10 Tg | SG and LG infl., ↓ SG and LG function | ↑ apoptosis in the SG | [95] |
Il14α Tg | SG infl., ↓ SG function | High incidence of CD5+ lymphoma, nephritis | [101] |
Baff Tg | SG and LG infl., ↓ SG function | MZ B-cell dominated infl., SLE-like disease | [106] |
Tgfβ1-/- | SG and LG infl., ↓ SG function | Poor viability, mixed inflammatory cell response | [112] |
Tgfβ1 Tg | ↓ SG function | Impaired SG architecture, SG tissue fibrosis | [113] |
Thbs1-/- | LG infl., anti-Ro and anti-La | Detailed assessment of the eye component | [116] |
Ar -/- | SG infl. | Estrogen-dependent disease | [119] |
RbAp48 Tg | SG and LG infl., ↓ SG function, anti-Ro and anti-La | Assessment of the inflammatory milieu in the SG | [122] |
Id3-/- | SG and LG infl., ↓ SG function, anti-Ro and anti-La | Exocrine gland dysfunction precedes SG and LG infl. | [125] |
Id3-/-;LckCre | SG and LG infl., ↓ SG function, anti-Ro and anti-La | T-cell lineage specific deletion of Id3 | [126] |
r1ΔT/r2n | SG and LG infl., anti-Ro | ↓ Tregs, inflammatory lesions in multiple organs | [130] |
IκBαM/M | SG and LG infl., anti-Ro and anti-La | Defective feedback regulation of NF-κB | [133] |
C57BL/10 | May develop SG infl. at an old age | C57BL/6 and C57BL/10 diverged prior to 1937 | |
NOD-Nss1/Idd5 | SG infl. | SG function has not been assessed | [82] |
SJL | SG and LG infl., anti-Ro and anti-La | Susceptible to multiple autoimmune diseases | [98] |
Il12 Tg | ↑ SG and LG infl., ↓ SG function, ↑ anti-Ro and anti-La | IL-12 exacerbates the SJL disease phenotype | [98] |
BALB/c | None | Often used as control strain | |
Act1-/- | SG and LG infl., anti-Ro and anti-La | MZ B-cell dominated infl., SLE-like disease | [115] |